1. Home
  2. MIGI vs INDP Comparison

MIGI vs INDP Comparison

Compare MIGI & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Inc.

HOLD

Current Price

$2.60

Market Cap

4.8M

Sector

Finance

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIGI
INDP
Founded
2012
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.5M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
MIGI
INDP
Price
$2.60
$1.75
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.1K
21.0K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.90
12.02
EPS
N/A
N/A
Revenue
$43,571,720.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.27
52 Week High
$15.80
$13.24

Technical Indicators

Market Signals
Indicator
MIGI
INDP
Relative Strength Index (RSI) 37.15 40.75
Support Level $0.36 $1.65
Resistance Level $3.50 $2.18
Average True Range (ATR) 0.24 0.16
MACD 0.00 -0.00
Stochastic Oscillator 14.29 18.30

Price Performance

Historical Comparison
MIGI
INDP

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: